Literature DB >> 29176594

Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling.

Yuichi Fujii1, Hironobu Umakoshi2, Norio Wada3, Takamasa Ichijo4, Kohei Kamemura5, Yuichi Matsuda6, Tatsuya Kai7, Tomikazu Fukuoka8, Ryuichi Sakamoto9, Atsushi Ogo9, Tomoko Suzuki10, Kazutaka Nanba2, Mika Tsuiki2, Mitsuhide Naruse2.   

Abstract

Subtype diagnosis of primary aldosteronism (PA) by adrenal vein sampling (AVS) is recommended as a mandatory step for indicating adrenal surgery. It is a technically demanding procedure, especially in the right adrenal vein. The aim of the study was to predict the subtype diagnosis in the absence of values from the right AVS. From the databases of nine centers (WAVES-J), 308 patients with PA who underwent successful AVS were studied. Based on the ipsilateral ratio (IR) (aldosterone/cortisol ratio of the left adrenal vein [A/Cleft AV] / aldosterone/cortisol ratio of the inferior vena cava [A/CIVC]), the patients were divided into two groups: the patients with IR ≥ 1.0 (n = 262) and those with IR < 1.0 (n = 46). In patients with IR > 1.0, the A/Cleft AV was significantly higher in patients with the left unilateral subtype than in patients with the bilateral subtype. Receiver operating characteristic (ROC) curve analysis revealed that an A/Cleft AV cutoff >68 showed 70.8% sensitivity and 93.5% specificity for the left unilateral subtype. On the other hand, in patients with IR < 1.0, the A/Cleft AV was significantly lower in patients with the right unilateral subtype. ROC analysis revealed that an A/Cleft AV cutoff <9 showed 86.7% sensitivity and 75.0% specificity for the right unilateral subtype. Hence, the combination of the IR and A/C ratio in the left adrenal vein is useful for predicting the subtype. The present results provide important information for patients with PA in whom AVS was unsuccessful in the right adrenal vein.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29176594     DOI: 10.1038/s41371-017-0015-0

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  30 in total

1.  Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism.

Authors:  Paolo Mulatero; Chiara Bertello; Norlela Sukor; Richard Gordon; Denis Rossato; Nicholas Daunt; David Leggett; Giulio Mengozzi; Franco Veglio; Michael Stowasser
Journal:  Hypertension       Date:  2010-02-01       Impact factor: 10.190

Review 2.  Primary aldosteronism. Diagnostic evaluation.

Authors:  W F Young; G G Klee
Journal:  Endocrinol Metab Clin North Am       Date:  1988-06       Impact factor: 4.741

3.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

4.  The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.

Authors:  Gian Paolo Rossi; Marlena Barisa; Bruno Allolio; Richard J Auchus; Laurence Amar; Debbie Cohen; Christoph Degenhart; Jaap Deinum; Evelyn Fischer; Richard Gordon; Ralph Kickuth; Gregory Kline; Andre Lacroix; Steven Magill; Diego Miotto; Mitsuhide Naruse; Tetsuo Nishikawa; Masao Omura; Eduardo Pimenta; Pierre-François Plouin; Marcus Quinkler; Martin Reincke; Ermanno Rossi; Lars Christian Rump; Fumitoshi Satoh; Leo Schultze Kool; Teresa Maria Seccia; Michael Stowasser; Akiyo Tanabe; Scott Trerotola; Oliver Vonend; Jiri Widimsky; Kwan-Dun Wu; Vin-Cent Wu; Achille Cesare Pessina
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

5.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

6.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Authors:  C E Fardella; L Mosso; C Gómez-Sánchez; P Cortés; J Soto; L Gómez; M Pinto; A Huete; E Oestreicher; A Foradori; J Montero
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  Adrenal venous sampling: evaluation of the German Conn's registry.

Authors:  Oliver Vonend; Nora Ockenfels; Xing Gao; Bruno Allolio; Katharina Lang; Knut Mai; Ivo Quack; Andreas Saleh; Christoph Degenhart; Jochen Seufert; Lysann Seiler; Felix Beuschlein; Marcus Quinkler; Petr Podrabsky; Martin Bidlingmaier; Reinhard Lorenz; Martin Reincke; Lars Christian Rump
Journal:  Hypertension       Date:  2011-03-07       Impact factor: 10.190

Review 8.  A review of the medical treatment of primary aldosteronism.

Authors:  P O Lim; W F Young; T M MacDonald
Journal:  J Hypertens       Date:  2001-03       Impact factor: 4.844

9.  Primary aldosteronism: adrenal venous sampling.

Authors:  W F Young; A W Stanson; C S Grant; G B Thompson; J A van Heerden
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

10.  Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma.

Authors:  Martin Wolley; Richard D Gordon; Eduardo Pimenta; Nicholas Daunt; Gregory J Slater; Ashraf H Ahmed; Michael Stowasser
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

View more
  4 in total

1.  Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Authors:  Yuichi Fujii; Yoshiyu Takeda; Isao Kurihara; Hiroshi Itoh; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Yui Shibayama; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Katsutoshi Takahashi; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Koichi Yamamto; Atsushi Ogo; Toshihiko Yanase; Shintaro Okamura; Shozo Miyauchi; Megumi Fujita; Tomoko Suzuki; Hironobu Umakoshi; Tatsuki Ogasawara; Mika Tsuiki; Mitsuhide Naruse
Journal:  J Hum Hypertens       Date:  2019-08-28       Impact factor: 3.012

Review 2.  Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Authors:  Finn Holler; Daniel A Heinrich; Christian Adolf; Benjamin Lechner; Martin Bidlingmaier; Graeme Eisenhofer; Tracy Ann Williams; Martin Reincke
Journal:  Curr Hypertens Rep       Date:  2019-09-03       Impact factor: 5.369

Review 3.  Primary aldosteronism.

Authors:  Sean M Wrenn; Anand Vaidya; Carrie C Lubitz
Journal:  Gland Surg       Date:  2020-02

4.  Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism.

Authors:  Mitsuhide Naruse; Akiyo Tanabe; Koichi Yamamoto; Hiromi Rakugi; Mitsuhiro Kometani; Takashi Yoneda; Hiroki Kobayashi; Masanori Abe; Youichi Ohno; Nobuya Inagaki; Shoichiro Izawa; Masakatsu Sone
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.